Galderma Group AG (FRA:PY30) Inventories, Work In Process : €0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Inventories, Work In Process?

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Galderma Group AG's work in process for the quarter that ended in Dec. 2024 was €0 Mil.

Galderma Group AG Inventories, Work In Process Historical Data

The historical data trend for Galderma Group AG's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Inventories, Work In Process Chart

Galderma Group AG Annual Data

Trend

Dec23

Dec24

Inventories, Work In Process

Galderma Group AG Semi-Annual Data
	Jun23	Dec23	Jun24	Dec24
Inventories, Work In Process	-	-	-	-

Galderma Group AG Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (FRA:PY30) » Definitions » Inventories, Work In Process

Comparable Companies

Traded in Other Exchanges

GALDY:USA GALDz:UK GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines